Chapter Two

Global Metabolic Partnering Analysis Report 2023: Trends, Players and Financials for 1,100+ Deals

Retrieved on: 
Samedi, mai 6, 2023

DUBLIN, May 5, 2023 /PRNewswire/ -- The "Global Metabolic Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 5, 2023 /PRNewswire/ -- The "Global Metabolic Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
  • The Global Metabolic Partnering 2016-2023 report provides comprehensive access to available deals and contract documents for over 1100 metabolic deals.
  • The report takes readers through the comprehensive metabolic disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering metabolic deals.
  • In addition, a comprehensive appendix is provided with each report of all metabolic partnering deals signed and announced since 2016.

Global Coronavirus Partnering Analysis Report 2023 with Directory of Over 1,500 Deals - Access to Headline, Upfront, Milestone and Royalty Data

Retrieved on: 
Jeudi, mai 4, 2023

The Global Coronavirus Partnering 2016-2023 report provides comprehensive access to available deals and contract documents for over 1500 coronavirus deals.

Key Points: 
  • The Global Coronavirus Partnering 2016-2023 report provides comprehensive access to available deals and contract documents for over 1500 coronavirus deals.
  • Chapter 6 provides a comprehensive directory of all coronavirus partnering deals by specific coronavirus target announced since 2016.
  • In addition, a comprehensive appendix is provided with each report of all coronavirus partnering deals signed and announced since 2016.
  • Global Coronavirus Partnering 2016 to 2023 includes:
    In Global Coronavirus Partnering 2016 to 2023, available deals and contracts are listed by:

Fintech Projected to Become a $1.5 Trillion Industry by 2030

Retrieved on: 
Mercredi, mai 3, 2023

NEW YORK, May 3, 2023 /PRNewswire/ -- Financial technology revenues are projected to grow sixfold from $245 billion to $1.5 trillion by 2030, according to a new report released today by Boston Consulting Group (BCG) and QED Investors. The fintech sector, which currently holds a 2% share of the $12.5 trillion in global financial services revenue, is estimated to grow up to 7%, of which banking fintechs are expected to constitute almost 25% of all banking valuations worldwide by 2030.

Key Points: 
  • The report, Global Fintech 2023: Reimagining the Future of Finance , provides a comprehensive overview of fintech's future landscape globally and explores the latest trends and opportunities in the global fintech market.
  • It also examines the regulatory environment for fintech companies and the impact of emerging technologies.
  • North America, which currently has the world's largest financial-services industry, will remain a critical fintech market and innovation hub, projected to grow fourfold to $520 billion in 2030, with the US accounting for a projected 32% of global fintech revenue growth (a CAGR of 17%).
  • The report projects a fintech revenue CAGR of 32% until 2030 in Africa, with South Africa, Nigeria, Egypt, and Kenya being the key markets.

Child labour on farms in Africa: it's important to make a distinction between what's harmful, and what isn't

Retrieved on: 
Lundi, mai 1, 2023

We examined a number of dimensions of children’s work in African agriculture in papers published in 2020 and 2022.

Key Points: 
  • We examined a number of dimensions of children’s work in African agriculture in papers published in 2020 and 2022.
  • It is certainly the case that some children are harmed by the work they do, and others may be forced to work, exploited or trafficked.
  • And critically, neither their interests, nor those of other rural children, are necessarily served by ongoing efforts to eradicate child labour from African agriculture.
  • First, by disrupting the dominant child labour discourse that pushes all children’s work, whether it be harmful or harmless, into the category of harmful child labour.

Key insights: harm and the school-work dichotomy

    • They note that harm remains a contested concept, despite being central to efforts to define and eradicate child labour, and having been theorised within various academic disciplines.
    • And harm arising from children’s work is likely to remain difficult to identify, assess and understand.
    • Nevertheless, progress could be made with an approach to harm which incorporates its subjective dimensions, including children’s lived experience of harm, and is focused on well-being.
    • The reality is that harm is experienced at school, and while travelling between home and school, as bullying, gender violence and physical abuse.

Don’t cause further harm

    • There are ongoing initiatives to eradicate child labour from a handful of global agricultural value chains, including the cocoa chain in West Africa.
    • As long as such initiatives fail to appreciate that much of the children’s work is harmless, and indeed beneficial, they have the potential to cause significant negative consequences – in fact, to harm – rural children and their families.

Stellantis on Track to Reach Bold Social and Environmental Targets

Retrieved on: 
Vendredi, avril 28, 2023

Holistic, 360-degree stakeholder approach to provide clean, safe and affordable mobility

Key Points: 
  • Holistic, 360-degree stakeholder approach to provide clean, safe and affordable mobility
    AMSTERDAM, April 28, 2023 - Stellantis today released its second Corporate Social Responsibility (CSR) Report delivering on its commitments and confirming dedicated focus to reaching its public social and environmental targets.
  • “We know the role and responsibility we have in addressing the environmental and social challenges that face our world, including embracing innovative solutions to preserve freedom of mobility for all,” said Carlos Tavares, Stellantis CEO.
  • Support brought by the Stellantis Foundation to world-class organizations and grassroots nonprofits empowering people through access to education.
  • For each CSR topic, Stellantis transparently published 2022 and 2021 results on key metrics related to short-, medium- and long-term targets.

Stellantis on Track to Reach Bold Social and Environmental Targets

Retrieved on: 
Vendredi, avril 28, 2023

Holistic, 360-degree stakeholder approach to provide clean, safe and affordable mobility

Key Points: 
  • Holistic, 360-degree stakeholder approach to provide clean, safe and affordable mobility
    AMSTERDAM, April 28, 2023 /PRNewswire/ -- Stellantis today released its second Corporate Social Responsibility (CSR) Report , delivering on its commitments and confirming dedicated focus to reaching its public social and environmental targets.
  • "We know the role and responsibility we have in addressing the environmental and social challenges that face our world, including embracing innovative solutions to preserve freedom of mobility for all," said Carlos Tavares, Stellantis CEO.
  • For each CSR topic, Stellantis transparently published 2022 and 2021 results on key metrics related to short-, medium- and long-term targets.
  • Stellantis N.V. (NYSE / MTA / Euronext Paris: STLA) is one of the world's leading automakers and a mobility provider.

Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 - ResearchAndMarkets.com

Retrieved on: 
Mercredi, avril 12, 2023

Global Central Nervous System Partnering 2016 to 2010 provides the full collection of central nervous system disease deals signed between the world's pharmaceutical and biotechnology companies since 2016.

Key Points: 
  • Global Central Nervous System Partnering 2016 to 2010 provides the full collection of central nervous system disease deals signed between the world's pharmaceutical and biotechnology companies since 2016.
  • The report takes readers through the comprehensive central nervous system disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering central nervous system deals.
  • Chapter 6 provides a comprehensive directory of all central nervous system partnering deals by specific central nervous system target announced since 2016.
  • Global Central Nervous System Partnering 2016 to 2023 is intended to provide the reader with an in-depth understanding and access to central nervous system trends and structure of deals entered into by leading companies worldwide.

Algae Biofuel Global Market Report 2022: Featuring Aecom, Eneos, Viridos, Manta Biofuels, Petronas & More - ResearchAndMarkets.com

Retrieved on: 
Mardi, avril 11, 2023

This report covers the present scenario and growth prospects of the global algae biofuel market for 2022-2027.

Key Points: 
  • This report covers the present scenario and growth prospects of the global algae biofuel market for 2022-2027.
  • The report also presents the market's competitive landscape and features a detailed profile of the key players operating in the market.
  • Chapter 4 presents an overview of the algae biofuel market, assesses market trends, drivers and challenges.
  • Chapter 5 discusses the algae biofuel market by region and gives the market forecast for 2027.

Global Gastrointestinal Partnering 2016-2023: Trends, Players and Financials of Over 480 Partnerships - ResearchAndMarkets.com

Retrieved on: 
Lundi, avril 3, 2023

The "Global Gastrointestinal Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Gastrointestinal Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
  • Global Gastrointestinal Partnering 2016 to 2023 provides the full collection of gastrointestinal disease deals signed between the world's pharmaceutical and biotechnology companies since 2016.
  • Chapter 6 provides a comprehensive directory of all gastrointestinal partnering deals by specific gastrointestinal target announced since 2016.
  • In Global Gastrointestinal Partnering 2016 to 2023, available deals and contracts are listed by:

Global Dermatology Partnering 2016-2023: Deal Trends, Players and Financials

Retrieved on: 
Vendredi, avril 7, 2023

DUBLIN, April 7, 2023 /PRNewswire/ -- The "Global Dermatology Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, April 7, 2023 /PRNewswire/ -- The "Global Dermatology Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
  • The Global Dermatology Partnering 2016-2023: Deal trends, players and financials report provides an understanding and access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies.
  • The report takes readers through the comprehensive dermatology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering dermatology deals.
  • The Global Dermatology Partnering 2016-2023 report provides comprehensive access to available deals and contract documents for over 700 dermatology deals.